Dr. McCarthy on Eligibility Criteria for Allogeneic BMT

Video

Philip L. McCarthy, MD, Director, Blood & Marrow Transplant Program, Department of Medicine, Roswell Park Cancer Institute, explains the factors that determine patient tolerability to allogeneic bone marrow transplant.

Philip L. McCarthy, MD, Director, Blood & Marrow Transplant Program, Department of Medicine, Roswell Park Cancer Institute, explains the eligibility criteria he uses to determine patient tolerability to allogeneic bone marrow transplant.

The upper age limit for patients eligible to undergo allogeneic bone marrow transplant has progressed from 50 years to 70 years since the 1980s. Some older patients remain eligible for allogeneic bone marrow transplant because of their overall health and activity, regardless of their age, McCarthy explains.

Patients with underlying kidney, heart or lung disease may not be able to handle the rigors of a transplant. McCarthy says that a 40-year-old with severe cardiac disease will not be an adequate allogeneic transplant candidate whereas a 70-year-old could be, based on comorbidities.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD